Completed PHASE4 INTERVENTIONAL NCT00206739

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants

Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial

Sponsor: Bernhard Nocht Institute for Tropical Medicine

Conditions Anemia Malaria

Interventions Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg)

Updated 5 times since 2017 Last updated: Mar 29, 2010 Started: Jan 31, 2003 Primary completion: Sep 30, 2005 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anemia and Malaria and is currently completed. Bernhard Nocht Institute for Tropical Medicine leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bernhard Nocht Institute for Tropical Medicine
Deutscher Akademischer Austausch Dienst
German Federal Ministry of Education and Research
The Volkswagen Foundation

Data source: Bernhard Nocht Institute for Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kumasi, Ghana